Abdominal pregnancy....extra uterine Placenta attached to fimbrial end of uterine tube on left side....

Most common type of ectopic pregnancy is A. Ovarian B. Abdominal C. Tubal D. Interstitial

cullen's sign discoloration around the umbilicus may indicate- 1 severe acute pancretitis 2 ruptured ectopic pregnancy 3 trauma to liver

A female came with acute lower abdominal pain of 24 hours duration . Vomiting and tachycardia . Ultrasound done . Patient had sterilisation surgery few years back . You can spot the diagnosis

SOGC GUIDELINES FOR ANTENATAL PROPHYLAXIS OF Rh NEGATIVE PREGNANCY RECOMMENDATIONS. 1.Anti-D 300 ug / IM or IV should be given within 72 hours of delivery to a postpartum non-sensitised Rh negative women delivering a Rh positive infant.Additional Anti-D Ig may be required for feto-maternal hemorrhage (FMH) greater than 15 ml of fetal red blood cells or 30 ml of fetal blood. 2.If Anti-D is not given within 72 hours of delivery or other potentally sensitizing event, Anti-D should be given as soon as the need is recognized,for upto 28 days after delivery or other potentially sensitising event (III-B) 3.There is poor evidence regarding inclusion or exclusion of routine testing for postpartum FMH ,as the cost-benefit of such testing in Rh mothers at risk has not been determined.(III-C) 4.Anti-D 300 ug should be given routinely to all Rh-negative non-sensitised women at 28 weeks when fetal blood type is unknown or known to be Rh positive. Alternatively ,2 doses of 100-120 ug may be given ,one at 28 weeks and other at 34 weeks. (I-A) 5.All pregnant women (D- negative or D-positive ) should be typed and screened for alloantibodies with an indirect anti-globulin test at the first prenatal visit and again at 28 weeks ( III- C) 6.When paternity is certain,Rh testing of the babys father may be offered to all Rh-negative pregnant women to eliminate unnecessary blood product administration (III-C) 7.A women with "weak D" should not receive Anti-D (III-D) 8.A repeat antepartum dose of Rh immunoglobulin is generally not required at 40 weeks ,provided that the antepartum injection was given no earlier than. 28 weeks.(III-C) 9.After a threatened abortion / miscarriage / induced abortion during the first 12 weeks gestation, non- sensitised D-negative women should be given a minimum Anti-D of 120ug. After 12 weeks gestation, they should be given 300 ug (II-3B) 10. At abortion,blood type and antibody screen should be done unless results of blood type and antibody screen during pregnancy are available ,in which case antibody screening need not be repeated (III-B ). 11.Anti-D should be given to non-sensitised D-negative women following ectopic pregnancy.A minimum of 120 ug should be given before 12 weeks gestation and 300 ug after 12 weeks gestation (III-B) 12.Anri-D should be given to non-sensitised D-negative women following molar pregnancy because of possibility of partial mole.Anti-D may be withheld if the diagnosis of complete mole is certain.(III-B) 13.At amniocentesis ,Anti-D 300 ug should be given to non-sensitised D-negative women (II-3B) 14.Anti-D should be given to non-sensitised D- negative women following chorionic villus sampling ,at a minimum dose of 120ug during the first 12 weeks of gestation , and at a dose of 300 ug after 12 weeks gestation (II-B) 15.Following cordocentesis,Anti-D of 300 ug should be given to non-sensitised D-negative women.(II-3B) 16.Quantitative testing for FMH may be considered following events potentially associated with placental trauma and disruption of the fetomaternal interface (placental abruption ,blunt trauma to the abdomen,cordocentesis,placenta previa with bleeding)There is substantial risk of FMH over 30 ml with such events) 17.Anti -D of 120ug or 300ug is recommended in association with testing to quantitate FMH following conditions potentially associated with placental trauma and disruption of fetomaternal interface. 18. Verbal or written informed consent must be obtained prior to administration of blood product Rh immune globulin 13. 9.